• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Alliqua Biomedical

Intarcia raises $225m to fund diabetes trial | Medtech funding for the week of April 27, 2015

May 1, 2015 By MassDevice Contributors Network

Intarcia adds $225m for Type II diabetes trial

April 28, 2015 by Brad Perriello

Filed Under: Diabetes, Funding Roundup, News Well Tagged With: Alliqua Biomedical, Contego Medical, Gynesonics, Hatteras Venture Partners, Intarcia Therapeutics, lombardmedical, Lookout Capital, Medical Mutual, Mountain Group Partners, Oxford Finance

Alliqua prices $30m offering

April 29, 2015 By Brad Perriello Leave a Comment

Alliqua prices $30m offering

Alliqua Biomedical (NSDQ:ALQA) today said it priced a public stock offering worth $30 million for its hydrogel wound care technology.

The Langhorne, Pa.-based company said it plan to offer nearly 6.9 million shares at $4.55 apiece.

Filed Under: Funding Roundup, News Well Tagged With: Alliqua Biomedical, Wound Therapy

Year in review: CEOs chime in on 2014

December 23, 2014 By MassDevice staff Leave a Comment

Year in review: CEOs chime in on 2014

As 2014 draws to a close, MassDevice.com asked several medical device company CEOs for their takes on 2014 and what they’re looking for in 2015.

We wanted to get their views on the major trends seen in medtech this year, including the red-hot M&A and IPO scenes, the medical device tax, the regulatory environment in the U.S., and more.

Filed Under: News Well Tagged With: Alliqua Biomedical, Arch Therapeutics, Edwards Lifesciences, Haemonetics, MassDevice.com, Neurometrix, OMNIlife Science Inc.

Wound care by the numbers: Q&A with Alliqua CEO Dave Johnson

August 15, 2014 By Arezu Sarvestani

Wound care by the numbers: Q&A with Alliqua CEO Dave Johnson

Alliqua Biomedical (NSDQ:ALQA) CEO Dave Johnson hasn’t been at the helm very long, but the company has seen a major turnaround during his time.

Filed Under: News Well, Regenerative Medicine, Wound Care Tagged With: Alliqua Biomedical, MassDevice Q&A, Wound Therapy

Alliqua board members and executives drive recent financing round

July 22, 2013 By Sony Salzman Leave a Comment

Alliqua logo

Wound dressing device maker Alliqua closed a $3 million equity financing round, largely backed by an insider group of board members and executives.

Alliqua drummed up the cash over the course of 3 months through sale of common stock, according to a company statement. Accredited investors paid 81¢ per share for equity, coupled with a warrant to purchase an additional share at 97¢ apiece.

Filed Under: Funding Roundup, News Well Tagged With: Alliqua Biomedical, Venture Capital/Private Equity, Wound Therapy

Medtronic home healthcare system cuts costs: Study | Research roundup

March 8, 2011 By MassDevice staff Leave a Comment

Clinical trials roundup

Medtronic Inc. (NYSE:MDT) said the results of a clinical trial for its new remote monitoring network indicate that the system reduces healthcare costs.

The study showed that monitoring of implantable cardiac device patients with the Medtronic’s CareLink network and CareAlert notification system cuts down on healthcare utilization costs when compared to in-office follow-up appointments, according to the company.

Filed Under: News Well Tagged With: Alliqua Biomedical, Clinical Trials, NanoLogix Inc., Osiris Therapeutics Inc.

HepaLife hopes for new life as Alliqua

December 23, 2010 By MassDevice staff Leave a Comment

HPLF logo

HepaLife Technologies Inc. (OTC:HPLF) is now Alliqua Inc.

Filed Under: Business/Financial News, News Well Tagged With: Alliqua Biomedical, HepaLife Technologies Inc.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy